Product Information
TRIAZOLAM 0.125 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2791 per EA under NDC 70710152101. Its NADAC has been published 167 times since Jun 14, 2023.
FDA first approved this application on Dec 28, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.125 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710152101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TRIAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA213003FDA Approved
12/28/2022
TE Code
AB
On Market Since
12/30/2022
Pharmacological Classes
Price Statistics
The NADAC for TRIAZOLAM 0.125 MG TABLET has been published 167 times since Jun 14, 2023, and over the history we have for it it has declined 68.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2791 per EA |
|---|---|
| All-time high | $0.9502 (Aug 16, 2023) |
| All-time low | $0.2219 (Jan 22, 2025) |
| 52-week high | $0.3975 |
| 52-week low | $0.2791 |
| Median price | $0.3652 |
| Average price | $0.4529 |
| Largest weekly change | -44.0% (Feb 21, 2024) |
| Weeks tracked | 167 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAZOLAM 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.125 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2791 per EA (NDC 70710152101), effective Aug 19, 2026.
How has the price of TRIAZOLAM 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIAZOLAM 0.125 MG TABLET has declined 68.0%. It has been tracked across 167 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.125 MG TABLET?
Since Jun 14, 2023, the NADAC for TRIAZOLAM 0.125 MG TABLET has ranged from a low of $0.2219 (Jan 22, 2025) to a high of $0.9502 (Aug 16, 2023), with a median of $0.3652 per EA.
Are there cheaper alternatives to TRIAZOLAM 0.125 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIAZOLAM 0.125 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAZOLAM 0.125 MG TABLET?
TRIAZOLAM 0.125 MG TABLET (NDC 70710152101) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.